MedPath

Clinical study of wrist-ankle acupuncture in treatment of refractory cancer pai

Phase 1
Recruiting
Conditions
Cancer
Registration Number
ITMCTR2000004104
Lead Sponsor
Jiangsu Province Hospital of Integrated Chinese and Western Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Pathological diagnosis of malignant tumors;
2. Meet the diagnostic criteria for refractory cancer pain: pain digital score (visual analogue scale, VAS score) >= 4 points and (or) burst pain >=3 times/day, follow the cancer pain treatment guidelines and use opioid-based drugs Unsatisfactory results and/or intolerable adverse reactions occur during 1~2 weeks of treatment;
3. Aged 18 to 75 years old, expected survival time >=3 months;
4. Clear consciousness, good compliance, fully understanding, and willingly join the study.

Exclusion Criteria

1. In addition to medication for pain relief, have used or are using analgesic radiotherapy, epidural analgesia pump or nerve block therapy;
2. Non-cancerous pain, such as surgical incision pain, lumbar disc herniation, sciatica, etc.;
3. Complicated with severe heart, liver, kidney, hematopoietic insufficiency, etc.;
4. Fainted needles or unable to cooperate with acupuncture treatment;
5. Allergy to oral analgesics;
6. Women are in pregnancy;
7. The patient undergoes other external Chinese medicine treatments during treatment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain degree;Break Pain;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath